BIGG

Hormonal contraceptive methods for women at high risk of HIV and living with HIV: 2014 guidance statement

During 9–12 March 2014, WHO convened a meeting of the Guideline Development Group (GDG) comprising 52 individuals representing a wide range of stakeholders, for the purpose of reviewing, and where appropriate, revising its Medical eligibility criteria for contraceptive use, fourth edition (MEC) guidanc...

Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children: recommendations for a public health approach: December 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection

World Health Organization.

In this second supplement (December 2014) to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, recommendations from two guideline development processes are included: post-exposure prophylaxis for HIV; the use of co-trimoxazole prophylaxis for H...

Infecciones por VIH/prevención & control, Profilaxis Posexposición/métodos, Poblaciones Vulnerables, Antiinfecciosos/administración & dosificación, Combinación Trimetoprim y Sulfametoxazol/administración & dosificación, Antirretrovirales/administración & dosificación, Infecciones Oportunistas Relacionadas con el SIDA/prevención & control, Factores de Riesgo, Infecciones por VIH/tratamiento farmacológico

Texto completo (enlace principal) Texto completo (enlace alternativo)